The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunocore Holdings plc ADR shares valued at $803,699 were sold by Berman David M on Sep 12 ’25. At $35.67 per share, Berman David M sold 22,532 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Berman David M sold 200 shares, netting a total of over 7,002 in proceeds. Following the sale of shares at $35.01 each, the insider now holds 0 shares.
Before that, Berman David M had sold 31,338 shares from its account. In a trade valued at $1,132,709, the HEAD OF R&D traded Immunocore Holdings plc ADR shares for $36.14 each. Upon closing the transaction, the insider’s holdings decreased to 31,338 shares, worth approximately $0.0.
Analysts at Deutsche Bank started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of December 13, 2024, Morgan Stanley has decreased its “an Overweight” rating to a “an Equal-weight” for IMCR. Earlier on November 11, 2024, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for IMCR stock which previously was a “an Outperform”.
Analyzing IMCR Stock Performance
On last trading session, Immunocore Holdings plc ADR [NASDAQ: IMCR] plunged -1.15% to $33.42. The stock’s lowest price that day was $33.37, but it reached a high of $34.47 in the same session. During the last five days, there has been a drop of approximately -8.21%. Over the course of the year, Immunocore Holdings plc ADR shares have dropped approximately -0.40%.
Is Immunocore Holdings plc ADR subject to short interest?
Stocks of Immunocore Holdings plc ADR saw a sharp rise in short interest on 2025-08-29 jumping by 0.39 million shares to 8.73 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 8.34 million shares. A jump of 4.48% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 27.92 of the overall float, the days-to-cover ratio (short ratio) jumped to 27.92.
Which companies own the most shares of Immunocore Holdings plc ADR (IMCR)?
In terms of Immunocore Holdings plc ADR share price expectations, FactSet research, analysts set an average price target of 68 in the next 12 months, up nearly 101.12% from the previous closing price of $33.81. Analysts anticipate Immunocore Holdings plc ADR stock to reach 100 by 2025, with the lowest price target being 24. In spite of this, 7 analysts ranked Immunocore Holdings plc ADR stock as Buy at the end of 2025. On October 24, 2024, UBS assigned a price target of “a Sell” to the stock and initiated coverage with a $24.
